Tirzepatide/ Sermorelin

Tirzepatide/ Sermorelin is administered via subcutaneous injection using a small insulin needle once or twice weekly as prescribed by your medical provider.

There is some pain associated with all injections. However, insulin needles are quite small, and with proper injection technique the pain is minimal. The best sites for injection include the fat in the abdomen and the buttocks.

Results derived from Tirzepatide/ Sermorelin therapy are variable from patient to patient and range from very subtle to profound depending on one’s individual needs and health status. Most patients notice some level of appetite suppression within their first few injections.

1. Do not use Semaglutide if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
2. Semaglutide may not be appropriate if you have a history of gastroparesis, pancreatitis, small bowel obstruction, or if you are on other blood-sugar lowering therapies.
3. Do not use Semaglutide if you have had a serious allergic reaction to Semaglutide or any of the ingredients in semaglutide prescription.
   
4. Do not use If you are pregnant or trying to become pregnant.
   
5. Sermorelin is not recommended for patients with a history of cancer.
   

The most common side effects of Semaglutide therapy include nausea, indigestion, constipation and/or diarrhea, and fatigue. Your medical provider will adjust your dose slowly and in response to your symptoms to minimize or avoid any potential symptoms.

Yes, Semaglutide may be used with other peptide therapies. Our team of medical providers will help determine which peptides are right for you and if it is appropriate to combine therapies during your monthly consultation.

No, we do not prescribe Semaglutide to pregnant or breast-feeding persons.

If you miss an injection contact your medical provider to see if the injection should be administered late or resumed on your next regularly scheduled injection day.